Cardiac Stem Cell Trial Halted Due to Concerns About Fake Data

Share this content:
Cardiac Stem Cell Trial Halted Due to Concerns About Fake Data
Cardiac Stem Cell Trial Halted Due to Concerns About Fake Data

MONDAY, Oct. 29, 2018 (HealthDay News) -- A clinical trial assessing the use of stem cells to treat heart failure patients has been paused by the U.S. National Heart, Lung, and Blood Institute (NHLBI) because it is based partly on what may be falsified or fabricated data from the laboratory of a Harvard Medical School-affiliated researcher.

The $63 million CONCERT-HF trial will remain on hold while its data and safety monitoring board conducts a review to ensure the trial meets the "the highest standards for participant safety and scientific integrity," the NHLBI said Monday. The patients in the study are being notified, and the follow-up protocol of the trial will be continued for all patients who have already been treated.

The trial was launched to investigate whether a certain type of cardiac stem cell, either alone or in combination with other stem cells from the bone marrow, is safe and benefits patients with chronic heart failure. The clinical trial is based on research from a number of laboratories, including that of Harvard-affiliated Brigham and Women's Hospital researcher Piero Anversa, M.D. The university recently announced that a years-long investigation discovered "falsified and/or fabricated data" in 31 papers from Anversa's laboratory, The Washington Post reported.

Anversa worked at the hospital until 2015. Last year, the hospital reached a $10 million settlement with the Justice Department to settle allegations that fake data were used by Anversa's laboratory in grant applications for federal funding.

More Information
Washington Post Article

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »